| Literature DB >> 22731758 |
Karin Brücher1, Boris Illarionov, Jana Held, Serena Tschan, Andrea Kunfermann, Miriam K Pein, Adelbert Bacher, Tobias Gräwert, Louis Maes, Benjamin Mordmüller, Markus Fischer, Thomas Kurz.
Abstract
Specific inhibition of enzymes of the non-mevalonate pathway is a promising strategy for the development of novel antiplasmodial drugs. α-Aryl-substituted β-oxa isosteres of fosmidomycin with a reverse orientation of the hydroxamic acid group were synthesized and evaluated for their inhibitory activity against recombinant 1-deoxy-d-xylulose 5-phosphate reductoisomerase (IspC) of Plasmodium falciparum and for their in vitro antiplasmodial activity against chloroquine-sensitive and resistant strains of P. falciparum . The most active derivative inhibits IspC protein of P. falciparum (PfIspC) with an IC(50) value of 12 nM and shows potent in vitro antiplasmodial activity. In addition, lipophilic ester prodrugs demonstrated improved P. falciparum growth inhibition in vitro.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22731758 DOI: 10.1021/jm300652f
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446